Journal
LEUKEMIA
Volume 25, Issue 3, Pages 506-514Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2010.280
Keywords
miR-126; miR-150; c-myb; thrombocyte; hematopoiesis; zebrafish
Categories
Funding
- NIH [CA93152]
- Leukemia and Lymphoma Research UK
Ask authors/readers for more resources
Precise regulatory mechanisms are required to appropriately modulate the cellular levels of transcription factors controlling cell fate decisions during blood cell development. In this study, we show that miR-126 is a novel physiological regulator of the proto-oncogene c-myb during definitive hematopoiesis. We show that knockdown of miR-126 results in increased c-Myb levels and promotes erythropoiesis at the expense of thrombopoiesis in vivo. We further provide evidence that specification of thrombocyte versus erythrocyte cell lineages is altered by the concerted activities of the microRNAs (miRNAs) miR-126 and miR-150. Both miRNAs are required but not sufficient individually to precisely regulate the cell fate decision between erythroid and megakaryocytic lineages during definitive hematopoiesis in vivo. These results support the notion that miRNAs not only function to provide precision to developmental programs but also are essential determinants in the control of variable potential functions of a single gene during hematopoiesis. Leukemia (2011) 25, 506-514; doi:10.1038/leu.2010.280; published online 16 November 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available